Cancer biotech ImmVirX taps Bell Potter for $20m pre-IPO
SYDNEY: The team behind ex-ASX listed biotech Viralytics – which was bought by global pharma
SYDNEY: The team behind ex-ASX listed biotech Viralytics – which was bought by global pharma
FEATURED
Property group reveals revised mixed-use housing development plans
Best retirement housing design for Global Awards shortlisted
Vision for affordable and sustainable multigenerational housing canvassed by experts
Intergenerational social housing boom in particular now underway
Study pinpoints mealtime issues in nursing home residents with dementia
Nursing home ownership moves represent major risk to future survival of sector
INNOVATION
